Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lung Kee Group Holdings's ROE % for the quarter that ended in Dec. 2025 was -2.42%. Lung Kee Group Holdings's PB Ratio for the quarter that ended in Dec. 2025 was 0.70.
Lung Kee Group Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -3.46%.
Lung Kee Group Holdings ROE % Adjusted to Book Value Related Terms
Lung Kee Group Holdings ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Lung Kee Group Holdings's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lung Kee Group Holdings ROE % Adjusted to Book Value Chart
HKSE:00255 vs CRS, ATI, MLI: ROE % Adjusted to Book Value Comparison
For the Metal Fabrication subindustry, Lung Kee Group Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lung Kee Group Holdings ROE % Adjusted to Book Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Lung Kee Group Holdings's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Lung Kee Group Holdings's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -3.46% mean?
Lung Kee Group Holdings (HKSE:00255) has a ROE % Adjusted to Book Value of -3.46% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Lung Kee Group Holdings and its competitors.
Is Lung Kee Group Holdings' ROE % Adjusted to Book Value too high?
Lung Kee Group Holdings' current ROE % Adjusted to Book Value is -3.46%. Overall, Lung Kee Group Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lung Kee Group Holdings' ROE % Adjusted to Book Value compare to CRS and ATI?
Lung Kee Group Holdings' ROE % Adjusted to Book Value of -3.46% can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Industrial Products company?
A good ROE % Adjusted to Book Value depends on the Industrial Products industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Lung Kee Group Holdings and its competitors. Lung Kee Group Holdings's current ROE % Adjusted to Book Value is -3.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lung Kee Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lung Kee Group Holdings (HKSE:00255) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$1.24, compared to a current price of HK$1.50 — trading 20.6% above its estimated fair value. The current ROE % Adjusted to Book Value is -3.46%. Lung Kee Group Holdings' overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Lung Kee Group Holdings (HKSE:00255), the current ROE % Adjusted to Book Value is -3.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lung Kee Group Holdings (HKSE:00255) Overvalued in 2026?
Based on GuruFocus' analysis, Lung Kee Group Holdings stock appears to be overvalued.
The current stock price of HK$1.50 is trading 20.6% above its estimated GF Value™ of HK$1.24.
GuruFocus considers Lung Kee Group Holdings to be Modestly Overvalued.
Key valuation signals for HKSE:00255:
ROE % Adjusted to Book Value: -3.46%
GF Value™: HK$1.24 vs. price of HK$1.50 (20.6% above fair value)
No single metric tells the full story. See the HKSE:00255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lung Kee Group Holdings Ltd is an investment holding company that provides corporate management services. Along with its subsidiaries, it is engaged in the manufacturing and marketing of mould bases and related products. Its product offerings include standard and custom-made mould base, mould components, tool and steel products such as plastic and steel mould, hot and cold work steel, precision plates, standard mould inserts, and other materials. The company generates a majority of its revenue from the People's Republic of China and the rest from other markets like Asia, Europe, and America.
67GF Score
Get the complete analysis for HKSE:00255
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00255 has been successfully added to your 
